![Michael Krohn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mr. Michael Krohn is a Co-Chief Executive Officer at Akribion Therapeutics.
Mr. Krohn was previously employed as a Head-Akribion Genomics Activities by BRAIN Biotech AG.
He received his doctorate degree from Heinrich-Heine-Universität Düsseldorf.
| Sociétés | Poste | Début |
|---|
| Sociétés | Poste | Fin |
|---|---|---|
| BRAIN BIOTECH AG | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Heinrich-Heine-Universität Düsseldorf
 Heinrich-Heine-Universität Düsseldorf Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BRAIN Biotech AG
 BRAIN Biotech AG BiotechnologyHealth Technology Discovers and develops bioactive natural compounds and proprietary enzymes | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
